Cerus (CERS) Non-Current Assets (2010 - 2026)
Cerus (CERS) posted Non-Current Assets of $47.9 million for Q2 2026, up 0.66% sequentially from $47.6 million in Q1 2026, and up 7.5% YoY from $44.5 million in Q2 2025.
Cerus (CERS) Non-Current Assets (2010 - 2026) Analysis & Trends
Cerus has reported Non-Current Assets for 17 years, with the latest figure at $47.9 million in Q2 2026.
- Quarterly Non-Current Assets rose 7.5% year-over-year to $47.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $191.0 million (up 1.79% YoY) and the FY2025 annual result came in at $47.5 million, down 2.9% from the prior year.
- Non-Current Assets rose to $47.9 million in Q2 2026 per CERS's latest filing, from $47.6 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $54.9 million in Q3 2023 and troughed at $44.5 million in Q2 2025.
- A 5-year average of $49.0 million and a median of $48.5 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 37.6% in 2022, then retreated 11.75% in 2025.
- Over 5 years, Non-Current Assets stood at $47.9 million in 2022, then gained by 11.18% to $53.3 million in 2023, then dropped by 8.28% to $48.9 million in 2024, then dropped by 2.9% to $47.5 million in 2025, then advanced by 0.85% to $47.9 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $47.9 million, $47.6 million, and $47.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 47.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.88 Mn |
| Mar 31, 2026 | 47.57 Mn |
| Dec 31, 2025 | 47.48 Mn |
| Sep 30, 2025 | 48.06 Mn |
| Jun 30, 2025 | 44.54 Mn |
| Mar 31, 2025 | 45.26 Mn |
| Dec 31, 2024 | 48.90 Mn |
| Sep 30, 2024 | 48.93 Mn |
| Jun 30, 2024 | 50.47 Mn |
| Mar 31, 2024 | 50.97 Mn |
| Dec 31, 2023 | 53.31 Mn |
| Sep 30, 2023 | 54.91 Mn |
| Jun 30, 2023 | 47.92 Mn |
| Mar 31, 2023 | 47.12 Mn |
| Dec 31, 2022 | 47.95 Mn |
| Sep 30, 2022 | 50.67 Mn |
| Jun 30, 2022 | 51.78 Mn |
| Mar 31, 2022 | 49.09 Mn |
| Dec 31, 2021 | 50.40 Mn |
| Sep 30, 2021 | 40.89 Mn |